We are live on ! Find out more
PG

Pendal Group Portfolio holdings

AUM $11.6B
1-Year Est. Return 12.87%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
-12.87%
3 Year Est. Return
+52.75%
5 Year Est. Return
+103.82%
10 Year Est. Return
–
AUM
$12.1B
AUM Growth
+$1.2B
Cap. Flow
+$1.49B
Cap. Flow %
12.26%
Top 10 Hldgs %
30.95%
Holding
675
New
129
Increased
199
Reduced
220
Closed
109

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$463M
2
BABA icon
Alibaba
BABA
+$168M
3
UNH icon
UnitedHealth
UNH
+$142M
4
LIN icon
Linde
LIN
+$136M
5
CHKP icon
Check Point Software Technologies
CHKP
+$129M

Top Sells

Rank Stock Value
1
PRAH
PRA Health Sciences, Inc.
PRAH
+$115M
2
MEDP icon
Medpace
MEDP
+$115M
3
ORCL icon
Oracle
ORCL
+$112M
4
MKSI icon
MKS Inc
MKSI
+$99.1M
5
ARMK icon
Aramark
ARMK
+$92.8M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 16.66%
3 Financials 15.34%
4 Consumer Discretionary 9.67%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFYA icon
101
Afya
AFYA
$1.35B
$14.9M 0.12%
754,141
+4,482
+0.6% +$102K
TFII icon
102
TFI International
TFII
$11.6B
$14.9M 0.12%
+145,693
New +$15.6M
BHC icon
103
Bausch Health
BHC
$1.75B
$14.9M 0.12%
534,290
+483,107
+944% +$13.7M
BPOP icon
104
Popular Inc
BPOP
$11B
$14.7M 0.12%
+189,509
New +$14.1M
BLK icon
105
Blackrock
BLK
$167B
$14.5M 0.12%
17,266
-2,688
-13% -$2.41M
QGEN icon
106
Qiagen
QGEN
$8.62B
$14.3M 0.12%
260,534
+17,766
+7% +$989K
NSC icon
107
Norfolk Southern
NSC
$75.4B
$14M 0.12%
58,319
-1,668
-3% -$428K
CME icon
108
CME Group
CME
$95.4B
$13.4M 0.11%
69,465
-4,225
-6% -$856K
INDA icon
109
iShares MSCI India ETF
INDA
$6.81B
$13.1M 0.11%
269,405
– –
SMIN icon
110
iShares MSCI India Small-Cap ETF
SMIN
$750M
$12.8M 0.11%
213,327
+33,486
+19% +$1.92M
GOOG icon
111
Alphabet (Google) Class C
GOOG
$4.11T
$12.6M 0.1%
94,900
-20,060
-17% -$2.77M
MRK icon
112
Merck
MRK
$322B
$12.1M 0.1%
160,861
-40,769
-20% -$3.1M
JD icon
113
JD.com
JD
$43.5B
$12M 0.1%
165,957
-88,332
-35% -$6.51M
CM icon
114
Canadian Imperial Bank of Commerce
CM
$106B
$11.7M 0.1%
210,128
+67,412
+47% +$3.88M
TME icon
115
Tencent Music
TME
$15.9B
$11.4M 0.09%
+1,577,138
New +$15.5M
PFE icon
116
Pfizer
PFE
$143B
$10.3M 0.09%
240,058
-93,946
-28% -$4.16M
INSW icon
117
International Seaways
INSW
$4.68B
$10.2M 0.08%
+562,540
New +$9.6M
PLD icon
118
Prologis
PLD
$136B
$10.1M 0.08%
80,307
-7,153
-8% -$928K
AUTL
119
Autolus Therapeutics
AUTL
$389M
$9.22M 0.08%
1,408,317
+875,067
+164% +$5.53M
GGB icon
120
Gerdau
GGB
$9.54B
$9.12M 0.08%
2,334,359
-563,446
-19% -$2.45M
TD icon
121
Toronto Dominion Bank
TD
$193B
$8.54M 0.07%
129,108
+91,622
+244% +$6.11M
WTW icon
122
Willis Towers Watson
WTW
$29.8B
$8.34M 0.07%
35,890
+10,212
+40% +$2.27M
EQIX icon
123
Equinix
EQIX
$99.4B
$8.26M 0.07%
10,457
+7,113
+213% +$5.91M
CSCO icon
124
Cisco
CSCO
$443B
$8.16M 0.07%
149,968
-89,364
-37% -$5.01M
WMT icon
125
Walmart Inc
WMT
$909B
$7.7M 0.06%
165,684
-88,110
-35% -$4.24M
3 4
5
6 7

Similar funds

RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PCA
Personal Capital Advisors Redwood City, California $20.6B AUM 13.65% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Pendal Group's Q3 2021 Portfolio in Review

As of Q3 2021, Pendal Group held 675 positions worth $12.1B, up 11% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pendal Group deployed $1.49B of net new capital in Q3 2021, opening 129 new positions and adding to 199 existing holdings. Its largest new stake was BioNTech: 1,455,825 shares worth $397M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Medpace, an estimated $115M trimmed.

  • Pendal Group's largest Q3 2021 buy was BioNTech: 1,455,825 shares worth $397M.
  • Pendal Group added most to Alibaba in Q3 2021, an estimated $168M increase.
  • Pendal Group's biggest Q3 2021 reduction was Medpace, cutting an estimated $115M.
  • Pendal Group fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $115M.
  • Pendal Group's ten largest holdings make up 31% of its $12.1B portfolio in Q3 2021.
  • Pendal Group opened 129 new positions and closed 109 in Q3 2021.
  • Pendal Group's portfolio value rose 11% quarter-over-quarter to $12.1B.

Based on Pendal Group's 13F filing for Q3 2021, filed 5 Nov 2021.